Next-generation intranasal Covid-19 vaccine: a polymersome-based protein subunit formulation that provides robust protection against multiple variants of concern …
JH Lam, D Shivhare, TW Chia, SL Chew, G Sinsinbar… - bioRxiv, 2022 - biorxiv.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of
coronavirus disease 2019 (Covid-19), an ongoing global public health emergency. Despite …
coronavirus disease 2019 (Covid-19), an ongoing global public health emergency. Despite …
[PDF][PDF] Next-generation intranasal Covid-19 vaccine: a polymersome-based protein subunit formulation that provides robust protection against multiple variants of …
JH Lam, D Shivhare, TW Chia, SL Chew, G Sinsinbar… - scholar.archive.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of
coronavirus disease 2019 (Covid-19), an ongoing global public health emergency. Despite …
coronavirus disease 2019 (Covid-19), an ongoing global public health emergency. Despite …
[PDF][PDF] Next-generation intranasal Covid-19 vaccine: a polymersome-based protein subunit formulation that provides robust protection against multiple variants of …
JH Lam, D Shivhare, TW Chia, SL Chew, G Sinsinbar… - researchgate.net
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of
coronavirus disease 2019 (Covid-19), an ongoing global public health emergency. Despite …
coronavirus disease 2019 (Covid-19), an ongoing global public health emergency. Despite …
[HTML][HTML] Next-generation intranasal Covid-19 vaccine: a polymersome-based protein subunit formulation that provides robust protection against multiple variants of …
JH Lam, D Shivhare, TW Chia, SL Chew, G Sinsinbar… - 2022 - europepmc.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of
coronavirus disease 2019 (Covid-19), an ongoing global public health emergency. Despite …
coronavirus disease 2019 (Covid-19), an ongoing global public health emergency. Despite …
Next-generation intranasal Covid-19 vaccine: a polymersome-based protein subunit formulation that provides robust protection against multiple variants of concern …
JH Lam, D Shivhare, TW Chia, SL Chew, G Sinsinbar… - bioRxiv, 2022 - biorxiv.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of
coronavirus disease 2019 (Covid-19), an ongoing global public health emergency. Despite …
coronavirus disease 2019 (Covid-19), an ongoing global public health emergency. Despite …